HIGHLIGHTS
- who: Tatsuya Hoshino and colleagues from the Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido have published the research work: Suppression of Alzheimer’s Disease-Related Phenotypes by Geranylgeranylacetone in Mice, in the Journal: PLOS ONE | www.plosone.org of March/21,/2013
- what: Since geranylgeranylacetone has already been approved for use as an antiulcer drug and its safety in humans has been confirmed the authors propose that this drug be considered as a candidate drug for the prevention of AD. The authors examined the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.